Who
Vivek K. Jayaraman
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Cerus; VP Global Sales and Marketing, TriVascular Technologies.
In numbers
- Trades disclosed
- 118
- Buys
- 0
- Sells
- 19
- Bought
- $0
- Sold
- $3.0M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 29 Nov 2013
- Last trade
- 16 Jul 2026
- Last filed
- 20 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jul 2026filed 20 Jul 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $53K16,666 at $3.16 | filing |
| 16 Jul 2026filed 20 Jul 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $53K16,666 at $3.16 | filing |
| 1 Jul 2026filed 2 Jul 2026 | CERS CerusMedical Devices | SEC FORM 4 Code A | —554,529 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | CERS Cerusoption or derivative · Medical Devices | SEC FORM 4 Code A | —369,686 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | CERS Cerusoption or derivative · Medical Devices | SEC FORM 4 Code A | —369,686 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | CERS CerusMedical Devices | SEC FORM 4 Code A | —554,529 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | CERS CerusMedical Devices | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $125K42,359 at $2.94 | filing |
| 30 Jun 2026filed 2 Jul 2026 | CERS CerusMedical Devices | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $125K42,359 at $2.94 | filing |
| 29 May 2026filed 2 Jun 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $50K16,667 at $3.00 | filing |
| 29 May 2026filed 2 Jun 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $50K16,667 at $3.00 | filing |
| 1 May 2026filed 5 May 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $50K16,667 at $3.00 | filing |
| 1 May 2026filed 5 May 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $50K16,667 at $3.00 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $274K165,200 at $1.66 | filing |
| 12 Mar 2026filed 16 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $274K165,200 at $1.66 | filing |
| 6 Mar 2026filed 9 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $68K34,094 at $2.01 | filing |
| 6 Mar 2026filed 9 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Sold | $69K34,094 at $2.01 | filing |
| 5 Mar 2026filed 9 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Code A | —80,320 at $0.00 | filing |
| 5 Mar 2026filed 9 Mar 2026 | CERS CerusMedical Devices | SEC FORM 4 Code A | —80,320 at $0.00 | filing |
News
TransMedics Group (NASDAQ:TMDX) and Cerus (NASDAQ:CERS) Head-To-Head ContrastCERS · themarketsdaily.com · 13 Oct 2026
0 headlines in the last 90 days name Vivek K. Jayaraman; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.